Production (Stage)
Anika Therapeutics, Inc.
ANIK
$11.24
-$0.53-4.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.37M | 55.63M | 62.37M | 62.82M | 68.63M |
| Total Receivables | 21.99M | 23.59M | 28.36M | 33.77M | 32.08M |
| Inventory | 21.34M | 23.81M | 39.63M | 51.46M | 49.41M |
| Prepaid Expenses | 5.82M | 5.49M | 5.75M | 6.94M | 8.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 5.13M | -- | -- | -- |
| Total Current Assets | 102.51M | 113.65M | 136.11M | 155.00M | 158.96M |
|
|
|||||
| Total Current Assets | 102.51M | 113.65M | 136.11M | 155.00M | 158.96M |
| Net Property, Plant & Equipment | 65.64M | 64.68M | 71.78M | 75.45M | 74.24M |
| Long-term Investments | 7.42M | 7.13M | 7.66M | 7.35M | 7.40M |
| Goodwill | 7.42M | 7.13M | 7.66M | 7.35M | 7.40M |
| Total Other Intangibles | 2.28M | 2.49M | 3.08M | 3.97M | 4.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.75M | 14.79M | 12.78M | 20.89M | 18.84M |
| Total Assets | 190.61M | 202.74M | 231.41M | 262.66M | 263.74M |
|
|
|||||
| Total Accounts Payable | 5.28M | 5.62M | 6.81M | 9.99M | 10.02M |
| Total Accrued Expenses | 9.91M | 11.59M | 16.31M | 13.25M | 12.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.87M | 1.92M | 2.29M | 2.29M | 2.13M |
| Total Finance Division Other Current Liabilities | 841.00K | 4.19M | 82.00K | 594.00K | 3.87M |
| Total Other Current Liabilities | 841.00K | 4.19M | 82.00K | 594.00K | 3.87M |
| Total Current Liabilities | 17.90M | 23.31M | 25.49M | 26.12M | 28.46M |
|
|
|||||
| Total Current Liabilities | 17.90M | 23.31M | 25.49M | 26.12M | 28.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.56M | 24.01M | 25.24M | 25.79M | 26.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 744.00K | 1.43M | 806.00K | 407.00K | 404.00K |
| Total Liabilities | 42.21M | 48.75M | 51.54M | 52.32M | 55.21M |
|
|
|||||
| Common Stock & APIC | 87.71M | 89.11M | 92.03M | 93.30M | 91.31M |
| Retained Earnings | 66.79M | 71.67M | 93.53M | 123.45M | 123.54M |
| Treasury Stock & Other | -6.10M | -6.78M | -5.70M | -6.42M | -6.32M |
| Total Common Equity | 148.40M | 153.99M | 179.86M | 210.34M | 208.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 148.40M | 153.99M | 179.86M | 210.34M | 208.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 148.40M | 153.99M | 179.86M | 210.34M | 208.54M |
|
|
|||||